Outlook Therapeutics Launches Public Offering of Stock and Warrants

Outlook Therapeutics Inc. has announced the launch of a public offering consisting of shares of its common stock and accompanying warrants.

Financial terms and the size of the offering were not immediately detailed in the initial announcement. The proceeds from the offering are typically allocated toward clinical development, regulatory submissions, and general corporate purposes.